前往化源商城

75-38-7 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL633738
Protocol: N/A
Comment: Journal: J. Med. Chem.
Year: 1985
Volume: 28
Issue: 3
First Page: 333
Last Page: 346
DOI: 10.1021/jm00381a013
Standard TypeStandard RelationStandard Value
LogP=-1.05
LogP=0.9
LogP=-0.24
LogP=0.62
LogP=0.7
LogP=0.18
LogP=0.48
LogP=-0.13
LogP=-0.24
LogP=-0.71
LogP=-0.3
LogP=0.75
LogP=2.99
LogP=2.46
LogP=2.27
LogP=1.85
LogP=0.18
LogP=-0.34
LogP=2.49
LogP=0.29
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:DTP/NCI 靶标:N/A
External ID: MCF7_OneDose
Protocol: NCI-60 Human Tumor Cell Lines Screen was performed using the standard one-dose NCI protocol, which is described in more detail at https://dtp.cancer.gov/discovery_development/nci-60/default.htm.

Compounds with GIPRCNT values below 10 were considered active. Activity score was based on GIPRCNT using the following formula:
max(-GIPRCNT/2 + 50, 0)
Score is 0 for GIPRCNT values of 100 or above, 50 for GIPRCNT values of 0, and 100 for GIPRCNT values of -100.
Comment: These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI National Service Center (NSC) number, which is contained in the
PUBCHEM_EXT_DATASOURCE_REGID field. In the NCI cell line identification system, MCF7 is panel number 5, cell number 1. PANELCODE or PANELNAME identify the NCI-60 cell panel. PANELNBR does NOT identify the NCI-60 panel.

EXPID is the NCI internal tracking number for the experiment identifier, and PREFIX = 'S' for the NSCs submitted through the NCI Chemical Agents repository.

Substance concentration unit is indicated in the data table, using the following abbreviations: M = molar (M), u = micrograms/milliliter (microg/mL), V = volumetric fraction.

M_GIPRCNT represents the mean growth percent for that experiment, and N_GIPRCNT indicates the number of values for that NSC within an experiment, while STDEV_GIPRCNT is the standard deviation. Most NSCs are tested once per experiment, resulting in EXP_COUNT = 1.
EXPIDPREFIXCONCENTRATION_UNITCONCENTRATIONPANELNBRCELLNBRPANELNAMECELLNAMEPANELCODEM_GIPRCNTN_GIPRCNTSTDDEV_GIPRCNTEXP_COUNT
2106OS49SM1.0E-551Breast CancerMCF7BRE88.231101
2106OS49SM1.0E-551Breast CancerMCF7BRE87.1119101
2106OS49SM1.0E-551Breast CancerMCF7BRE14.4371101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.7113101
2106OS49SM1.0E-551Breast CancerMCF7BRE97.2463101
2106OS49SM1.0E-551Breast CancerMCF7BRE90.0129101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.7031101
2106OS49SM1.0E-551Breast CancerMCF7BRE30.8539101
2106OS49SM1.0E-551Breast CancerMCF7BRE14.2896101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.8526101
2106OS49SM1.0E-551Breast CancerMCF7BRE83.1036101
2106OS49SM1.0E-551Breast CancerMCF7BRE84.2194101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.3237101
2106OS49SM1.0E-551Breast CancerMCF7BRE85.6034101
2106OS49SM1.0E-551Breast CancerMCF7BRE89.6643101
2106OS52SM1.0E-551Breast CancerMCF7BRE91.2503101
2106OS52SM1.0E-551Breast CancerMCF7BRE94.8714101
2106OS52SM1.0E-551Breast CancerMCF7BRE93.7372101
2106OS52SM1.0E-551Breast CancerMCF7BRE112.6132101
2106OS52SM1.0E-551Breast CancerMCF7BRE73.375101
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:DTP/NCI 靶标:N/A
External ID: IGROV1_OneDose
Protocol: NCI-60 Human Tumor Cell Lines Screen was performed using the standard one-dose NCI protocol, which is described in more detail at https://dtp.cancer.gov/discovery_development/nci-60/default.htm.

Compounds with GIPRCNT values below 10 were considered active. Activity score was based on GIPRCNT using the following formula:
max(-GIPRCNT/2 + 50, 0)
Score is 0 for GIPRCNT values of 100 or above, 50 for GIPRCNT values of 0, and 100 for GIPRCNT values of -100.
Comment: These data are a subset of the data from the NCI human tumor cell line screen. Compounds are identified by the NCI National Service Center (NSC) number, which is contained in the
PUBCHEM_EXT_DATASOURCE_REGID field. In the NCI cell line identification system, IGROV1 is panel number 6, cell number 10. PANELCODE or PANELNAME identify the NCI-60 cell panel. PANELNBR does NOT identify the NCI-60 panel.

EXPID is the NCI internal tracking number for the experiment identifier, and PREFIX = 'S' for the NSCs submitted through the NCI Chemical Agents repository.

Substance concentration unit is indicated in the data table, using the following abbreviations: M = molar (M), u = micrograms/milliliter (microg/mL), V = volumetric fraction.

M_GIPRCNT represents the mean growth percent for that experiment, and N_GIPRCNT indicates the number of values for that NSC within an experiment, while STDEV_GIPRCNT is the standard deviation. Most NSCs are tested once per experiment, resulting in EXP_COUNT = 1.
EXPIDPREFIXCONCENTRATION_UNITCONCENTRATIONPANELNBRCELLNBRPANELNAMECELLNAMEPANELCODEM_GIPRCNTN_GIPRCNTSTDDEV_GIPRCNTEXP_COUNT
0809OS51SM1.0E-5610Ovarian CancerIGROV1OVA89.6274101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA94.0185101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA77.1805101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA76.1686101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA82.5618101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA88.7561101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA83.5845101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA92.7497101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA70.9555101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA58.7306101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA72.6041101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA90.3839101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA110.2345101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA97.6538101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA93.7697101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA56.4618101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA80.8893101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA79.078101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA-20.3008101
0810OS71SM1.0E-5610Ovarian CancerIGROV1OVA72.0949101
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:25294 靶标:N/A
External ID: cpdb
Protocol: N/A
Comment: N/A
CAS#Chemical CodeTD50SpeciesStrainSexRouteTissueTumorOpinionHistoricInadequateBerkeley MixesMandatoryXpo TimeXpr TimeNotesStepLifetableP-valueLower ConfidenceUpper ConfidencePlotted SymbolPound SignNdosesCurveNdsigControl TotalPoolTumors CountData NumberIDPaper NumberSourcePubMed IDCitation
78-79-5isr25800MouseB6C3F1MaleInhalationspleenhemangiosarcoma008096es0.56634601.0E31$10149018436672258nLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr247MouseB6C3F1FemaleInhalationpituitary glandpars distalis adenoma+080105es0.02297.11.0E31%2*249018436412258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr319MouseB6C3F1FemaleInhalationHarderian glandadenoma+080105es0.0261221.0E31$2*249028436422258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr682MouseB6C3F1FemaleInhalationspleenhemangiosarcoma+h80105es0.0962011.0E31$2*250018436432258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr1.0E31MouseB6C3F1FemaleInhalationliverhepatocellular carcinoma0080105es13221.0E31$20250028436442258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr1.0E31MouseB6C3F1FemaleInhalationliverhepatocellular adenoma0080105es13101.0E31$20250048436452258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr1.0E31MouseB6C3F1FemaleInhalationlungalveolar/bronchiolar adenoma0080105es12271.0E31$20250058436462258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr881MouseB6C3F1MaleInhalationHarderian glandadenoma+080105es06011430%5*547048436682258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr1570MouseB6C3F1MaleInhalationliverhepatocellular adenoma+080105es08914070$5*5500118436692258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr1660MouseB6C3F1MaleInhalationlungalveolar/bronchiolar adenoma+080105es09973620$5*5500118436702258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr6680MouseB6C3F1MaleInhalationlungalveolar/bronchiolar carcinoma+080105es0402028800$5*550008436712258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr22200MouseB6C3F1MaleInhalationforestomachsquamous-cell carcinoma+080105es0.0077680740000$5*550008436722258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr4850MouseB6C3F1MaleInhalationliverhepatocellular carcinoma+080105es0.02120001.0E31$5*550098436732258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr15000MouseB6C3F1MaleInhalationHarderian glandcarcinoma+080105es0.01661001.0E31$5*547008436742258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr45000MouseB6C3F1MaleInhalationforestomachsquamous-cell papilloma0080105es0.068111001.0E31$5*550008436752258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr39000MouseB6C3F1MaleInhalationhearthemangiosarcoma+h80105es0.30880701.0E31$5*549008436762258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr150000MouseB6C3F1MaleInhalationlymphoreticular systemhistiocytic sarcoma0080105es0.82184501.0E31$5*550008436772258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
78-79-5isr1.0E31MouseB6C3F1MaleInhalationspleenhemangiosarcoma0080105es1135001.0E31$50549018436782258oLiterature8901906M E :Placke;Toxicology,113,253-262;1996
26675-46-7isu30000MouseSwiss WebsterFemaleInhalationlungalveolar-cell adenoma-078810s0.23586701.0E31%2*2920155403701879Literature3189921J M :Baden;Anesthesiology,69,750-753;1988
26675-46-7isu1.0E31MouseSwiss WebsterFemaleInhalationliverbasophil adenoma-078810s1360001.0E31$20292015403711879Literature3189921J M :Baden;Anesthesiology,69,750-753;1988